with all the latest ARMI news and events. We know your inbox is overflowing, so we promise to only share important news and events with you - we hate SPAM too.

Filter by

A newly published paper in the prominent science journal ‘Nature Methods’ revealed that human pluripotent stem cells have distinct functional and molecular features when generated through various methods. This discovery, realised by the Australian Regenerative Medicine Institutes (ARMI) Polo Group, offers a new comprehensive study in the field of stem cell research. The findings were led by PhD student Ethan Liu and senior Postdoc Christian Nefzger.

ARMI Annual Report 2016

Annual reports / 9 October 2017
ARMI annual report 2016 cover page

2016 saw yet another year of exceptional research excellence at the Australian Regenerative Medicine Institute (ARMI). The number of papers published in leading journals with an impact factor of greater than 10, more than doubled in 2016.

The year was bolstered with new opportunities to commercialise research at the Institute, with the announcement of a global hub of commercialisation at ARMI, the Centre for Commercialisation of Regenerative Medicine Australia.

If you looked beyond the outstanding career of Dr Zita Unger as an evaluator, educator and entrepreneur, you would discover that she is a keen diver with extensive experience in the Pacific, Micronesia and Australian waters. For Dr Zita Unger, however, the exploring does not stop in the watery depths. When on dry land, Dr Unger investigates opportunities for ARMI.

Associate Professor Andrew Laslett’s Group at ARMI is focussed on investigating the biology of human pluripotent stem cell lines, including human ESC and iPSC. Thanks to the Laslett Group, the study and application of human embryonic stem cells has recently been advanced by the availability of new antibodies which can easily determine which cells in a cell population are pluripotent.